What is the recommended treatment for gonorrhea and acute bacterial prostatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Gonorrhea and Prostatitis

For gonorrhea, administer ceftriaxone 1 g intramuscularly or intravenously plus azithromycin 1 g orally as a single dose; for acute bacterial prostatitis, initiate broad-spectrum antibiotics such as intravenous piperacillin-tazobactam, ceftriaxone, or oral ciprofloxacin for 2-4 weeks. 1, 2

Gonorrhea Treatment Algorithm

First-line therapy:

  • Ceftriaxone 1 g intramuscularly or intravenously as a single dose PLUS azithromycin 1 g orally as a single dose 1
  • Intravenous ceftriaxone is increasingly preferred as it is safe, effective, and avoids the discomfort of intramuscular injection 1

Alternative regimens when cephalosporins cannot be used:

  • Cefixime 400 mg orally single dose plus azithromycin 1 g orally single dose 1
  • For cephalosporin allergy: Gentamicin 240 mg intramuscularly single dose plus azithromycin 2 g orally single dose 1
  • Gemifloxacin 320 mg orally single dose plus azithromycin 2 g orally single dose 1
  • Spectinomycin 2 g intramuscularly single dose 1
  • Fosfomycin trometamol 3 g orally on days 1,3, and 5 1

Critical diagnostic steps:

  • Perform nucleic acid amplification testing (NAAT) on first-void urine or urethral smear before treatment to confirm diagnosis 1
  • Obtain urethral swab culture before treatment initiation in NAAT-positive patients to assess antimicrobial resistance patterns 1
  • Test for pharyngeal infection in all cases of urogenital treatment failure, as pharyngeal infections are usually asymptomatic and may harbor resistant strains 1
  • Treat sexual partners while maintaining patient confidentiality 1

Acute Bacterial Prostatitis Treatment Algorithm

First-line therapy for acute bacterial prostatitis:

  • Broad-spectrum intravenous or oral antibiotics for 2-4 weeks 2
  • Intravenous piperacillin-tazobactam, ceftriaxone, or oral ciprofloxacin achieve 92-97% success rates 2
  • Gram-negative bacteria (E. coli, Klebsiella, Pseudomonas) cause 80-97% of cases 2

Hospitalization criteria - use intravenous antibiotics when:

  • Patient is systemically ill with fever or chills 2, 3
  • Unable to voluntarily urinate 3
  • Unable to tolerate oral intake 3
  • Risk factors for antibiotic resistance are present 3

Outpatient oral therapy options:

  • Ciprofloxacin (fluoroquinolone first-line) 2, 4
  • Trimethoprim-sulfamethoxazole if pathogen is susceptible 4
  • Doxycycline if pathogen is susceptible 4

Key diagnostic findings to confirm acute bacterial prostatitis:

  • Pelvic pain with urinary tract symptoms (dysuria, frequency, retention) 2, 3
  • Systemic symptoms: fevers, chills, nausea, emesis, malaise 2, 3
  • Digital rectal examination reveals tender, enlarged, or boggy prostate 3
  • Obtain urine cultures in all suspected cases to identify bacteria and antibiotic sensitivities 3

Chronic Bacterial Prostatitis Treatment

For chronic bacterial prostatitis (persistent infection presenting as recurrent UTIs):

  • Minimum 4-week course of levofloxacin or ciprofloxacin 2, 4
  • May require up to 12 weeks of therapy for complete eradication 4
  • Up to 74% caused by gram-negative organisms, particularly E. coli 2
  • Fosfomycin has emerged as a useful alternative for multidrug-resistant pathogens 4

Important Caveats

Antimicrobial resistance considerations:

  • Use pathogen-directed treatment based on local resistance data whenever possible 1
  • Ertapenem 1 g intramuscularly single dose showed non-inferiority to ceftriaxone for anogenital gonorrhea, though data on resistant strains is limited 1
  • Novel agents (zoliflodacin, gepotidacin) are in phase 3 trials for gonorrhea but not yet available 1

Prostate tissue penetration challenges:

  • Few antimicrobials achieve adequate prostatic tissue concentrations 4, 5
  • Fluoroquinolones remain first-line due to superior prostate penetration 4, 5
  • Prolonged therapy is essential for chronic forms due to poor drug penetration 5

Risk of treatment failure:

  • Pharyngeal gonorrhea is frequently asymptomatic and may require extended-spectrum cephalosporin therapy with additional doses and longer duration 1
  • Chronic bacterial prostatitis has high recurrence rates requiring prolonged treatment 4, 5
  • Prostatic abscesses may require surgical intervention if antibiotics fail 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prostatitis: A Review.

JAMA, 2025

Research

Acute Bacterial Prostatitis: Diagnosis and Management.

American family physician, 2016

Research

How I manage bacterial prostatitis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023

Research

The harmful effects of overlooking acute bacterial prostatitis.

International journal of urology : official journal of the Japanese Urological Association, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.